Aerpio Pharmaceuticals, Inc. (ARPO)

Trade ARPO now with
9/15/2020 8:47:08 AM Aerpio Says Enrollment Completed In 28-Day Phase 2 Razuprotafib Glaucoma Trial
6/24/2020 8:14:48 AM Aerpio Begins 28-Day Phase 2 Razuprotafib Glaucoma Trial
1/8/2020 8:46:28 AM Aerpio Announces New Results From Fifth Cohort Of Subjects From A Phase 1b Trial
10/21/2019 5:02:31 AM Aerpio Pharma Initiates A Process To Explore And Review A Range Of Strategic Alternatives
3/18/2019 7:12:05 AM Aerpio Pharma Says TIME-2b Study Did Not Meet Primary Endpoint
11/7/2018 7:12:31 AM Aerpio Pharma Q3 Net Income $11.5 Mln Or $0.28/shr Vs. Net Loss $4.6 Mln Or $0.17/shr Last Year
8/14/2018 7:08:11 AM Aerpio Q2 Loss Per Share $0.22 Vs Loss $0.21 Last Year
6/25/2018 4:08:40 PM Aerpio Pharmaceuticals Announces Proposed Public Offering Of Common Stock
6/25/2018 7:04:37 AM Aerpio Announces Exclusive License Agreement With Gossamer Bio For AKB-4924
5/15/2018 7:16:38 AM Aerpio Pharma Q1 Loss Attributable To Shareholders $7.4 Mln Or $0.27/Shr Vs Loss $5.9 Mln Or $1.06/Shr Last Year